Literature DB >> 12099776

Assessment and measurement of cough: the value of new tools.

K F Chung1.   

Abstract

On systematic investigation, patients with persistent cough are often diagnosed as having asthma, gastro-oesophageal reflux (GOR) and post-nasal drip; often, there is no associated diagnosis. Cough-variant asthma and eosinophilic bronchitis are conditions presenting with cough, usually associated with airway eosinophilia and responding well to corticosteroids. These conditions including asthma are best grouped as 'eosinophil-associated cough'. Analysis of induced sputum for eosinophils is an important tool in the investigation of chronic persistent cough. Reliable ambulatory counters for cough have been developed and the contribution of cough count and intensity to the severity of cough have been partly evaluated, and used in assessing antitussive therapies. Self-scoring evaluations are still widely used, but the inclusion of quality of life tools specifically adapted to the evaluation of cough appears to be a useful tool that can directly measure the impact of chronic cough. We need a greater assessment and evaluation of all these tools. Copyright 2002 Published by Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12099776     DOI: 10.1006/pupt.2002.0360

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  11 in total

Review 1.  Recent additions in the treatment of cough.

Authors:  Nicole M Ryan; Peter G Gibson
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Tracheal activity recognition based on acoustic signals.

Authors:  Temiloluwa Olubanjo; Maysam Ghovanloo
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2014

3.  A retrospective study of theophylline-based therapy with tracheal collapse in small-breed dogs: 47 cases (2013-2017).

Authors:  So Young Jeung; Sang June Sohn; Ju Hyun An; Hyung Kyu Chae; Qiang Li; Mincheol Choi; Junghee Yoon; Woo Jin Song; Hwa Young Youn
Journal:  J Vet Sci       Date:  2019-09       Impact factor: 1.672

4.  Efficacy and safety of the syrup "KalobaTUSS®" as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trial.

Authors:  Ilaria Carnevali; Rita La Paglia; Lara Pauletto; Floriana Raso; Marco Testa; Carmen Mannucci; Emanuela Elisa Sorbara; Gioacchino Calapai
Journal:  BMC Pediatr       Date:  2021-01-11       Impact factor: 2.125

Review 5.  Past and Trends in Cough Sound Acquisition, Automatic Detection and Automatic Classification: A Comparative Review.

Authors:  Antoine Serrurier; Christiane Neuschaefer-Rube; Rainer Röhrig
Journal:  Sensors (Basel)       Date:  2022-04-10       Impact factor: 3.847

6.  Inhibition of citric acid- and capsaicin-induced cough by novel TRPV-1 antagonist, V112220, in guinea-pig.

Authors:  Sum Yee Leung; Akio Niimi; Alison S Williams; Puneeta Nath; F-Xavier Blanc; Q Thai Dinh; K Fan Chung
Journal:  Cough       Date:  2007-12-23

7.  Measuring cough severity: Perspectives from the literature and from patients with chronic cough.

Authors:  Nancy Kline Leidy; Alise Nacson; Linda Nelsen; Margaret Vernon
Journal:  Cough       Date:  2009-03-19

8.  Efficacy and safety of Qing-Feng-Gan-Ke Granules in patients with postinfectious cough: study protocol of a novel-design phase III placebo-controlled, double-blind randomized trial.

Authors:  Wei Liu; Hongli Jiang; Ruiming Zhang; Faguang Jin; Liangji Liu; Youyu Long; Liying Cui; Suyun Li; Yunqing Zhong; Bing Mao
Journal:  BMC Complement Altern Med       Date:  2015-08-19       Impact factor: 3.659

9.  Resuscitation and auto resuscitation by airway reflexes in animals.

Authors:  Zoltan Tomori; Viliam Donic; Roman Benacka; Jan Jakus; Sona Gresova
Journal:  Cough       Date:  2013-08-22

10.  Efficacy of Grintuss® pediatric syrup in treating cough in children: a randomized, multicenter, double blind, placebo-controlled clinical trial.

Authors:  Mario Canciani; Vitalia Murgia; Davide Caimmi; Sreedhar Anapurapu; Amelia Licari; Gian Luigi Marseglia
Journal:  Ital J Pediatr       Date:  2014-06-10       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.